Arromax pharmatech, co. ltd.   product pipeline review - 2014
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share

Arromax pharmatech, co. ltd. product pipeline review - 2014

  • 87 views
Uploaded on

This report provides comprehensive information on the current therapeutic developmental pipeline of Arromax Pharmatech, Co. Ltd.’s, complete with comparative analysis at various stages,......

This report provides comprehensive information on the current therapeutic developmental pipeline of Arromax Pharmatech, Co. Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

More in: Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
87
On Slideshare
87
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014 Global Markets Direct’s, ‘Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014’, provides an overview of the Arromax Pharmatech, Co. Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Arromax Pharmatech, Co. Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides brief overview of Arromax Pharmatech, Co. Ltd. including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Arromax Pharmatech, Co. Ltd.’s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Arromax Pharmatech, Co. Ltd.’s pipeline products Reasons to buy Evaluate Arromax Pharmatech, Co. Ltd.’s strategic position with total access to detailed information on its product pipeline Assess the growth potential of Arromax Pharmatech, Co. Ltd. in its therapy areas of focus Identify new drug targets and therapeutic classes in the Arromax Pharmatech, Co. Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of Arromax Pharmatech, Co. Ltd. and exploit collaboration and partnership opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arromax Pharmatech, Co. Ltd. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of Arromax Pharmatech, Co. Ltd. and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues table Of Content arromax Pharmatech, Co. Ltd. Snapshot arromax Pharmatech, Co. Ltd. Overview key Information key Facts arromax Pharmatech, Co. Ltd. - Research And Development Overview key Therapeutic Areas arromax Pharmatech, Co. Ltd. - Pipeline Review pipeline Products By Stage Of Development pipeline Products - Monotherapy arromax Pharmatech, Co. Ltd. - Pipeline Products Glance arromax Pharmatech, Co. Ltd. - Early Stage Pipeline Products preclinical Products/combination Treatment Modalities arromax Pharmatech, Co. Ltd. - Drug Profiles amx-1008 product Description mechanism Of Action r&d Progress amx-2004 product Description mechanism Of Action r&d Progress amx-3002 product Description mechanism Of Action r&d Progress arromax Pharmatech, Co. Ltd. - Pipeline Analysis arromax Pharmatech, Co. Ltd. - Pipeline Products By Target arromax Pharmatech, Co. Ltd. - Pipeline Products By Molecule Type arromax Pharmatech, Co. Ltd. - Pipeline Products By Mechanism Of Action arromax Pharmatech, Co. Ltd. - Locations And Subsidiaries head Office other Locations & Subsidiaries Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014
  • 2. appendix methodology coverage secondary Research primary Research expert Panel Validation contact Us disclaimer ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014